Русский

Pharmaceutical Industry Information Portal

News Feed

Drug manufacturers

Vladimir Khristenko resigns as President of Nanolek

Techno -
Co-founder of Nanolek Vladimir Khristenko announced his intention to step down as President, the post he has been holding...

Nacimbio is Launching a New Drug for the Treatment of Immunodeficiencies

Techno -
NPO Microgen, a company of the Naimbio holding, is launching on the market the first domestic human normal immunoglobulin...

Pharmstandard will construct a new production facility in Ufa

Techno -
The investment project will be implemented in 2023–2025. The total amount of investment is estimated to be 2.6 billion...

Regulatory News

Rules of import and export of biomaterials produced during clinical trials of drugs become effective in Russia

Techno -
Rules of import and export of biomaterials produced during clinical trials of drugs become effective in Russia from September...

FDA approves Sanofi’s Dupixent for widespread use in the United States

Ekaterina -
Sanofi won expanded U.S. approval for its best-selling Dupixent injection to treat an allergic inflammation of the esophagus, the...

U.S.FDA lifts ban on COVAXIN Covid-19 vaccine candidate study

Ekaterina -
Ocugen, Inc., a biotechnology company focused on discovering, developing, and commercializing novel gene therapies, biologicals, and vaccines, May 23th...

World Pharma News

Binnopharm Group brings its popular antispasmodic to Azerbaijan

Techno -
Binnopharm Group, a pharmaceutical company and part of Sistema, continues to expand its footprint in the CIS markets. Neobutin,...

Amgen sells its Turkish manufacturing arm for $135M

Ekaterina -
Amgen, which has been beefing up its U.S. manufacturing operations, sold its stake in Turkey’s oldest pharmaceutical company Gensenta...

Pfizer and BioNTech announce new $3.2 billion agreement to supply the COVID-19 vaccine to the US

Ekaterina -
Pfizer Inc. and BioNTech SE announced today a new vaccine supply agreement with the U.S. government, according to which...

Don’t miss your daily PharmProm news.
SUBSCRIBE free here!

SUBSCRIBE

Expert Articles

GMP-inspections of veterinary manufacturers in the second half of 2022

Techno -
This year, specialists of the Federal State Budgetary Institution "The All-Russian State Center for Quality and Standardization of Veterinary...

GMP-inspections of veterinary manufacturers in the first half of 2022

Techno -
The review provides information related to the inspection of manufacturers of medicinal products for veterinary use for compliance with...

Combination of biomarkers discovered that can to identify subcortical small-vessel disease

Ekaterina -
In recent years, subcortical small-vessel disease has become an increasingly common cognitive diagnosis. Researchers at University of Gothenburg have...

Research and Development

Rules of import and export of biomaterials produced during clinical trials of drugs become effective in Russia

Techno -
Rules of import and export of biomaterials produced during clinical trials of drugs become effective in Russia from September...

Sanofi-GSK’s Covid vaccine, effective against omicron, could hit the market this year

Ekaterina -
Sanofi and GSK today announce positive data from their vaccine trial which evaluated an adjuvanted bivalent D614 and Beta...

OSE Immunotherapeutics collaborates with Microsoft to further develop its digital infrastructures

Ekaterina -
OSE Immunotherapeutics SA today announces that the Company is one of the first biotech startup companies selected by Microsoft...

Market analytics

Hikma Pharmaceuticals down 30%, stock to buy on fall

Ekaterina -
Hikma Pharmaceuticals is one of the biggest UK biotech stocks, only trailing giants like AstraZeneca and GlaxoSmithKline. Hikma was...

Pfizer, BioNTech shares rise after FDA approves Covid boosters for children

Ekaterina -
Pfizer Inc. and BioNTech SE May 17th announced the U.S. Food and Drug Administration (FDA) expanded emergency use authorization...

Sales of AstraZeneca’s COVID vaccine exceed forecasts Q1 revenue $11.39 billion

Ekaterina -
AstraZeneca PLC said Friday that it expects sales of total revenue from COVID-19 medicines is anticipated to decline by...

Information Internet project PharmProm.Net dedicated to the pharmaceutical industry in the world. It contains a contact base of organizations, enterprises, companies associated with the pharmaceutical market. The editorial staff of the PharmProm.Net portal offers cooperation in the field of information promotion and advertising in the pharmaceutical market.

Read our Russian-language online magazine

Categories